Researchers from James Cook University have identified a number of peripheral blood biomarkers associated with an increased incidence of abdominal aortic aneurysm (AAA). These biomarkers are being explored as targets for compounds to treat AAA and for developing a sensitive diagnostic assay to prognose, diagnose, and monitor the progression of AAA.